PREDICTION AND PERSONALIZED PREVENTION OF AN UNFAVORABLE COURSE OF PARKINSON’S DISEASE: From Functional-Latent Changes to Functional-Organic Decompensation
Year: 2026
Type: article
Abstract: Background. Parkinson’s disease is one of the fastest-growing neurological disorders and increasingly represents not only a motor disease, but also a chronic condition with heterogeneous rates of disability, non-motor deterioration and loss of independence. Objective. This narrative review summarizes current evidence on unfavorable disease course in Parkinson’s disease and proposes a clinically oriented model for prediction and personalized prevention of functional-organic decompensation. Materials and methods. A narrative literature search was performed in PubMed, Scopus, Web of Science and Google Scholar. Publications from 2020 to 2026 were prioritized, with additional inclusion of major consensus papers and highly cited earlier sources. Results. Contemporary literature has moved from static motor phenotypes toward longitudinal disease course, clinically meaningful milestones, biological markers and multimodal prediction. An unfavorable course can be interpreted as a sequential process with three levels: functional-latent insufficiency, functional-manifest cognitive-regulatory decompensation and organic-mixed decompensation. A practical minimum set of markers can include clinical scales, functional tests, brain MRI and a limited blood panel reflecting neuroaxonal injury, glial activation, mixed proteinopathy, neuroplastic reserve, inflammation and neurosomatic vulnerability. Plasma NfL, GFAP, p-tau181, BDNF, TNF-alpha and 25-hydroxyvitamin D are reasonable candidates for such a minimal panel. Conclusions. Prediction of an unfavorable course should not be reduced to the detection of a single symptom or a single biomarker. The most clinically useful approach is to identify the transition from compensated disease to functional-regulatory instability and then to organic-mixed decompensation, with early personalized measures aimed at preserving independence and preventing irreversible functional loss.
Authors: Rakhimbaeva, G.S., Okhunova, D.A.
Institution: Tashkent State Medical University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: Parkinson's disease, disease progression prediction, personalized prevention, biomarkers, neurofilament light chain, glial fibrillary acidic protein, p-tau181, brain-derived neurotrophic factor, TNF-α, 25-hydroxyvitamin D, neuroaxonal damage, glial activation, inflammation, brain MRI, functional testing
Open Access status: diamond
OpenAlex ID: W7216947367
